Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
69.60
+0.40 (0.58%)
Nov 16, 2026, 5:35 PM CET
BME:ROVI Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, BME:ROVI stock has a consensus rating of "Buy" and an average price target of €75.00. The average 1-year stock price forecast is 7.76% higher than the current stock price, while the lowest is €67.00 (-3.74%) and the highest is €89.00 (+27.87%).
Price Target: €75.00 (+7.76%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for BME:ROVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains €83.50 → €64.20 | Hold | Maintains | €83.50 → €64.20 | -7.76% | May 14, 2026 |
Financial Forecast
Revenue This Year
796.91M
from 743.48M
Increased by 7.19%
Revenue Next Year
901.85M
from 796.91M
Increased by 13.17%
EPS This Year
3.06
from 2.75
Increased by 11.28%
EPS Next Year
3.29
from 3.06
Increased by 7.66%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.